drugset / Trial / NCT03470337
Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Oral enzyme therapy in patients with acute superficial vein inflammation (thrombophlebitis) can serve as an additional treatment option besides standard therapy with compression stockings, common pain medication and physical treatments. This randomized, double-blinded trial compares efficacy and safety with placebo.
Timeline
- Start
- 1996-09
- Primary completion
- 1997-06
- Completion
- 1997-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phlogenzym | Unknown | 6 unknown | Oral |